AMN Healthcare Services (AMN) Price Target Cut by JMP Securities to $22.00
ByAinvest
Tuesday, Aug 12, 2025 7:29 pm ET1min read
AMN--
Analysts have responded to these results with varied opinions. JMP Securities' Constantine Davides maintained a "Market Outperform" rating but reduced the price target from $33 to $22, a 33.33% decrease [3]. This adjustment was echoed by BMO Capital, which also lowered its price target from $27 to $22, citing a more cautious outlook on AMN's potential growth [2]. The average target price from seven analysts is $22, with estimates ranging from $18 to $33, indicating a potential 33.41% upside from the current price of $16.49 [3].
Despite the downward revision in price targets, AMN's stock has shown resilience. The company's shares are currently trading at $16.87, down from $16.73 a week ago, but up from a low of $14.87 over the past year [2]. The estimated GF Value in one year is $50.52, suggesting a potential 206.37% upside [3].
AMN Healthcare Services continues to operate as a leading player in the healthcare staffing industry, offering a range of workforce solutions and staffing services to healthcare facilities across the United States. The company's ability to meet and exceed financial targets in certain areas, such as its allied staffing business, highlights its potential for future growth.
References:
[1] https://finance.yahoo.com/news/amn-healthcare-services-second-quarter-133140781.html
[2] https://site.financialmodelingprep.com/market-news/amn-healthcare-services-strong-q2-2025-financials-industry-leadership
[3] https://www.gurufocus.com/news/3048076/q2-2025-amn-healthcare-services-inc-earnings-call-transcript
Analyst Constantine Davides from JMP Securities has maintained a "Market Outperform" rating for AMN Healthcare Services (AMN) but lowered the price target from $33 to $22, a 33.33% decrease. The average target price from 7 analysts is $22, with a high estimate of $33 and a low of $18, implying a 33.41% upside from the current price of $16.49. The estimated GF Value in one year is $50.52, suggesting a 206.37% upside.
AMN Healthcare Services (NYSE: AMN) reported its second-quarter 2025 results, revealing mixed financial performance. The company posted revenue of $658.2 million, a 11% decline from the same period last year [1]. Despite the revenue decrease, the net loss was $116.2 million, down from a profit of $16.2 million in the previous quarter, with earnings per share (EPS) falling to $3.03 from $0.42 [1].Analysts have responded to these results with varied opinions. JMP Securities' Constantine Davides maintained a "Market Outperform" rating but reduced the price target from $33 to $22, a 33.33% decrease [3]. This adjustment was echoed by BMO Capital, which also lowered its price target from $27 to $22, citing a more cautious outlook on AMN's potential growth [2]. The average target price from seven analysts is $22, with estimates ranging from $18 to $33, indicating a potential 33.41% upside from the current price of $16.49 [3].
Despite the downward revision in price targets, AMN's stock has shown resilience. The company's shares are currently trading at $16.87, down from $16.73 a week ago, but up from a low of $14.87 over the past year [2]. The estimated GF Value in one year is $50.52, suggesting a potential 206.37% upside [3].
AMN Healthcare Services continues to operate as a leading player in the healthcare staffing industry, offering a range of workforce solutions and staffing services to healthcare facilities across the United States. The company's ability to meet and exceed financial targets in certain areas, such as its allied staffing business, highlights its potential for future growth.
References:
[1] https://finance.yahoo.com/news/amn-healthcare-services-second-quarter-133140781.html
[2] https://site.financialmodelingprep.com/market-news/amn-healthcare-services-strong-q2-2025-financials-industry-leadership
[3] https://www.gurufocus.com/news/3048076/q2-2025-amn-healthcare-services-inc-earnings-call-transcript
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet